These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27819744)

  • 1. Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer.
    Liu HX; Li J; Ye BG
    Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms in DNA repair genes
    Alsagaby S; Ahmed AA; Rasheed Z; Althwab SA; Aljohani ASM; Alhumaydhi FA; Alhomaidan HT; Alkhamiss AS; Alkhowailed M; Alaqeel A; Alblihed MA; Alrehaili J; Fernández N; Abdulmonem WA
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(5-6):530-554. PubMed ID: 35319340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population.
    Kiyohara C; Horiuchi T; Takayama K; Nakanishi Y
    J Thorac Oncol; 2012 Jun; 7(6):954-62. PubMed ID: 22525558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
    Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
    Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer.
    Liu JY; Liu QM; Li LR
    Genet Mol Res; 2015 Aug; 14(3):10331-7. PubMed ID: 26345972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India.
    Ghosh S; Ghosh S; Bankura B; Saha ML; Maji S; Ghatak S; Pattanayak AK; Sadhukhan S; Guha M; Nachimuthu SK; Panda CK; Maity B; Das M
    Tumour Biol; 2016 Jul; 37(7):9139-49. PubMed ID: 26768611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
    Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A
    J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].
    Wang N; Wu Y; Zhou X; Wu Y
    Wei Sheng Yan Jiu; 2012 Mar; 41(2):251-6. PubMed ID: 22611936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation of combined OGG1, CYP1A1 and GSTP1 gene variants and risk of lung cancer of male Iraqi waterpipe tobacco smokers.
    Kudhair BK; Alabid NN; Zayed KS; Lafta IJ; Taheri-Kafrani A
    Mol Biol Rep; 2020 Jul; 47(7):5155-5163. PubMed ID: 32577993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.
    Li F; Wang J; Chen M
    Biomed Pharmacother; 2016 Mar; 78():92-100. PubMed ID: 26898429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma.
    Smedby KE; Lindgren CM; Hjalgrim H; Humphreys K; Schöllkopf C; Chang ET; Roos G; Ryder LP; Falk KI; Palmgren J; Kere J; Melbye M; Glimelius B; Adami HO
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):258-65. PubMed ID: 16492913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair pathway genes and lung cancer susceptibility: a meta-analysis.
    Li W; Li K; Zhao L; Zou H
    Gene; 2014 Apr; 538(2):361-5. PubMed ID: 24368330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-environment interactions between ERCC2, ERCC3, XRCC1 and cadmium exposure in nasal polyposis disease.
    Khlifi R; Olmedo P; Gil F; Hammami B; Hamza-Chaffai A; Rebai A
    J Appl Genet; 2017 May; 58(2):221-229. PubMed ID: 27838878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
    Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
    Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study.
    He L; Gao L; Shi Z; Li Y; Zhu L; Li S; Zhang P; Zheng G; Ren Q; Li Y; Hu B; Feng F
    PLoS One; 2015; 10(3):e0119481. PubMed ID: 25798582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.